Combined Research Orlando Phase I IV

Clinical research site in Orlando, Florida · Combined Research Orlando, 1417 N Semoran Blvd #106, Orlando, FL 32807 · (407) 440-4493 · Website

As of July 2026, 8 paid clinical trials are recruiting at Combined Research Orlando Phase I IV in Orlando, Florida. Active studies at this site cover conditions such as Coronavirus Disease (COVID-19), Major Depressive Disorder and Bipolar I Disorder. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Combined Research Orlando Phase I IV (8)

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

for Coronavirus Disease (COVID-19)

61 locations incl. Paradise Valley

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06667700·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"

for Major Depressive Disorder

43 locations incl. Phoenix

Sponsor: Cybin IRL Limited

Sex: All·Age: 18 - 85

Code: NCT06564818·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

for Bipolar I Disorder

33 locations incl. Huntsville

Sponsor: AbbVie

Sex: All·Age: 18 - 65

Code: NCT06696755·Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

ACP-204 in Adults With Alzheimer's Disease Psychosis

for Alzheimer's Disease Psychosis

29 locations incl. Chandler

Sponsor: ACADIA Pharmaceuticals Inc.

Sex: All·Age: 55 - 95

Code: NCT06159673·Phase 2, Phase 3·Recruiting·Listed Dec 2023

Apply to this trial

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

for Agitation Associated With Alzheimer's Dementia

24 locations incl. Anaheim

Sponsor: Intra-Cellular Therapies, Inc.

Sex: All·Age: 55+

Code: NCT06651567·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type

for Agitation

27 locations incl. Anaheim

Sponsor: Suven Life Sciences Limited

Sex: All·Age: 50 - 90

Code: NCT05397639·Phase 3·Recruiting·Listed May 2022

Apply to this trial

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

for Major Depressive Disorder

45 locations incl. Phoenix

Sponsor: Xenon Pharmaceuticals Inc.

Sex: All·Age: 18 - 74

Code: NCT06775379·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)

for Gout

18 locations incl. Little Rock

Sponsor: Protalix

Sex: All·Age: 18+

Code: NCT07280156·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

More research sites in Orlando

AdventHealth Orlando (60 trials)
Arnold Palmer Hospital for Children (37 trials)
Nemours Children's Hospital (37 trials)
Orlando Health (31 trials)
University of Central Florida (31 trials)
Orlando Health Cancer Institute (30 trials)
AdventHealth (28 trials)
Advent Health (17 trials)
Orlando Clinical Research Center (17 trials)
Charter Research (11 trials)

Explore more

Paid clinical trials in Orlando, FL · Florida clinical trials